Research & Publications
Recent publications on liquid biopsy
| No. | Publication details |
|---|---|
| 1 | The liver niche accelerates, while the lung niche restrains secondary spread of breast cancer Sznurkowska MK, Castro-Giner F, D’Anna I, Krol I, Zhang Y, Ozimski LL, Saini M, Zhou J, Asawa S, Gremmelspacher D, Ring A, Strittmatter K, Schwab FD, Zhang YW, Budinjas S, Vujanovic M, Kontarakis Z, Pontecorvi G, Albrecht F, Mertz KD, Auray G, Giachino C, Taylor V, Gvozdenovic A, Kovacs WJ, Malanchi I, Frauchiger-Heuer H, Wicki A, Vetter M, Ligorio M, Aceto N. Cancer Discov. 2026 Sep 22. doi: 10.1158/2159-8290.CD-25-1652. Epub ahead of print. PMID: 42770697. |
| 2 | Ki-67 promotes circulating tumor cell intravasation and metastasis in breast cancer Zhang Y, Zhou J, Strittmatter K, Zhang YW, Waldmeier M, Asawa S, Vujanovic M, Budinjas S, Saini M, Ildiz ES, Gvozdenovic A, Kovacs W, Castro-Giner F, Aceto N. Cell Rep. 2026 May 26;45(5):117354. doi: 10.1016/j.celrep.2026.117354. Epub 2026 May 15. PMID: 42139058. |
| 3 | Liquid biopsies for detection, characterization, and interception of therapy resistance in thoracic malignancies Oner E, M Saini V, Cahill C, O’Toole H, Li JW, Gately K, Anagnostou V. Front Oncol. 2026 Aug 10;16:1806868. doi: 10.3389/fonc.2026.1806868. PMID: 42639369; PMCID: PMC13501364. |
| 4 | Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers Landon BV, Huang J, Evangelopoulou EG, Anagnostou V, Canzoniero JV. Int Rev Cell Mol Biol. 2026;399:113-143. doi: 10.1016/bs.ircmb.2024.12.002. Epub 2024 Dec 14. PMID: 41720562. |
| 5 | Liquid biopsies across the cancer care continuum Landon BV, Annapragada AV, Niknafs N, Velculescu VE, Anagnostou V. Nat Med. 2025 Dec;31(12):4006-4021. doi: 10.1038/s41591-025-04093-9. Epub 2025 Dec 10. PMID: 41372534; PMCID: PMC13429241. |
| 6 | Robust Automated Separation of Circulating Tumor Cells and Cancer-Associated Fibroblasts for Enhanced Liquid Biopsy in Breast Cancer Woo HJ, Rademacher PN, Shin HY, Lee J, Intisar A, Warkiani ME, Joung JY, Rzhevskiy A, Coith C, Harten F, Hilpert F, Schmalfeldt B, Riethdorf S, Pantel K, Joosse SA, Kim MS. Anal Chem. 2025 Aug 19;97(32):17452-17461. doi: 10.1021/acs.analchem.5c02154. Epub 2025 Jul 14. PMID: 40658815. |
| 7 | International expert consensus on the clinical integration of circulating tumor cells in solid tumors Nicolò E, Reduzzi C, Pierga JY, Gazzaniga P, Stoecklein NH, Denninghoff V, Rothwell DG, De Bono JS, Marchetti D, Lianidou E, Riethdorf S, Generali D, Hofman P, Gerratana L, Kuhn P, Thiery JP, Ignatiadis M, Bidard FC, Lucci A, Kasimir-Bauer S, Serrano MJ, Cristofanilli M. Eur J Cancer. 2025 Dec 9;231:116050. doi: 10.1016/j.ejca.2025.116050. Epub 2025 Oct 20. Erratum in: Eur J Cancer. 2026 Jan 17;233:116167. doi: 10.1016/j.ejca.2025.116167. PMID: 41172567. |
| 8 | Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS) Pantel K, Alix-Panabières C, Hofman P, Stoecklein NH, Lu YJ, Lianidou E, Giacomini P, Koch C, de Jager V, Deans ZC, Fairley J, Patton SJ, Toledo RA, Schuuring E, Heitzer E, Hendrix A, Ricklefs FL, Thakur BK, von Bubnoff N, Pierga JY, Gebhardt C, Andersen CL, Fijneman R, Malats N, Hallermayr A, Chelala C, Joosse SA, Ciliberto G. J Exp Clin Cancer Res. 2025 May 23;44(1):156. doi: 10.1186/s13046-025-03398-4. PMID: 40410806; PMCID: PMC12100835. |
| 9 | Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis Janni W, Friedl TWP, Yab TC, Bidard FC, Cristofanilli M, Hayes DF, Ignatiadis M, Regan MM, Alix-Panabieres C, Barlow WE, Caldas C, Carey LA, Dirix L, Fehm T, Garcia-Saenz JA, Gazzaniga P, Generali D, Gerratana L, Gisbert-Criado R, Jacot W, Jiang Z, Joosse SA, Lianidou E, López López R, Magbanua MJM, Manso L, Mavroudis D, Müller V, Munzone E, Pantel K, Pierga JY, Rack B, Riethdorf S, Rugo HS, Sideras K, Sleijfer S, Smerage J, Stebbing J, Terstappen LWMM, Vidal-Martínez J, Wallwiener M, Giridhar KV, Liu MC. Clin Cancer Res. 2025 Jun 3;31(11):2196-2209. doi: 10.1158/1078-0432.CCR-24-3108. PMID: 40100138; PMCID: PMC12130808. |
| 10 | HER2 phenotyping of CTCs in breast cancer: a comparison across the spectrum of tissue HER2 expression level Molteni E, Foffano L, Pontolillo L, Nicolò E, Pastò B, Guimaraes G, Bayou N, Serafini MS, Gianni C, D’Amico P, Andreopoulou E, Davis AA, Gradishar WJ, Puglisi F, Cristofanilli M, Gerratana L, Reduzzi C. J Liq Biopsy. 2026 Sep 30;14:100667. doi: 10.1016/j.jlb.2026.100667. PMID: 42890328; PMCID: PMC13671332. |
| 11 | The Landscape of Tumor Dissemination in Leptomeningeal Disease: Mapping CTC Plasticity and Regional Heterogeneity Across Blood and CSF Compartments Shishido SN, Chaudhuri B, Mushran V, Ihle K, Wang Y, Egelston CA, Hicks J, Feldman L, Barragan E, Kuhn P. Cancers (Basel). 2026 Sep 26;18(19):3124. doi: 10.3390/cancers18193124. PMID: 42882819. |
Recent publications on liquid biopsy from HSLB members
| No. | Publication details |
|---|---|
| 1 | ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study Stergiopoulou D, Markou A, Nicolo E, Serafini MS, Zhang Q, Zhang Y, Gerratana L, Davis AA, Liu H, Gradishar WJ, Reduzzi C, Cristofanilli M, Lianidou E. Mol Oncol. 2026 Aug;20(8):2102-2113. doi: 10.1002/1878-0261.70254. Epub 2026 May 27. PMID: 42201922; PMCID: PMC13398972. |
| 2 | Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients Werner S, Tennstedt P, Pose RC, Müller C, Besler K, Schneegans S, Alawi M, Roesch MC, Peine S, Bonci D, Budna-Tukan J, Lianidou E, Alix-Panabières C, Tilki D, Pantel K. Mol Oncol. 2026 Mar 26:10.1002/1878-0261.70244. doi: 10.1002/1878-0261.70244. Epub ahead of print. PMID: 41885368; PMCID: PMC13398947. |
| 3 | Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4 Mangani K, Pantazaka E, Lianidou E, Georgoulias V, Kotsakis A, Markou A, Kallergi G. Ther Adv Med Oncol. 2026 Feb 15;18:17588359261416422. doi: 10.1177/17588359261416422. PMID: 41705139; PMCID: PMC12907484. |
| 4 | The phenotypic heterogeneity of tumor-derived cells in the bloodstream of pancreatic cancer patients Tagari C, Mangani K, Gogolides M, Roumeliotou A, Golegou P, Xagara A, Koinis F, Frisan T, Pateras IS, Karagiannis SN, Kotsakis A, Kallergi G. Front Cell Dev Biol. 2026 Sep 14;14:1881239. doi: 10.3389/fcell.2026.1881239. PMID: 42807419; PMCID: PMC13617025. |
| 5 | The Impact of Combretastatin A-4 on Cancer Cells and Circulating Tumor Cells (CTCs): A Multi-Assay Approach Papakonstantinou D, Vardas V, Varouhaki DM, Kotzamouratoglou A, Mangani K, Ju JA, Alix-Panabières C, Martin SS, Athanassopoulos CM, Kallergi G. Oncol Res. 2026 Sep 14;34(10):1. doi: 10.32604/or.2026.085665. PMID: 42769799; PMCID: PMC13591330. |
| 6 | Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approach Papakonstantinou D, Roumeliotou A, Pantazaka E, Shaukat AN, Christopoulou A, Koutras A, Dimitrakopoulos FI, Georgoulias V, Xagara A, Chantzara E, Koinis F, Kotsakis A, Stathopoulos C, Kallergi G. Mol Oncol. 2025 Jul;19(7):2038-2055. doi: 10.1002/1878-0261.13765. Epub 2024 Nov 22. PMID: 39575761; PMCID: PMC12234381. |
| 7 | Detection rate for ESR1 mutations is higher in circulating-tumor-cell-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR Smilkou S, Ntzifa A, Tserpeli V, Balgkouranidou I, Papatheodoridi A, Razis E, Linardou H, Papadimitriou C, Psyrri A, Zagouri F, Kakolyris S, Lianidou E. Mol Oncol. 2025 Jul;19(7):2109-2119. doi: 10.1002/1878-0261.13787. Epub 2025 Jan 4. PMID: 39754401; PMCID: PMC12234389. |
| 8 | Development and Broad Application of a Double Drop-Off ddPCR Assay for Simultaneous Detection of Four FGFR3 Mutations in Tissue and Liquid Biopsy Samples Thanou E, Gavalas N, Kabrani E, Grigoriou F, Konstantinou A, Malamatini V, Chourdaki Peristeri C, Lianidou E, Bamias A, Markou A. Cancers (Basel). 2026 Aug 14;18(16):2634. doi: 10.3390/cancers18162634. PMID: 42649945; PMCID: PMC13510398. |
| 9 | AXL-mRNA Overexpression in Size-Based Enriched Circulating Tumor Cells as a Potential Biomarker for Anti-AXL Targeted Therapies in Non-Small-Cell Lung Cancer Ntzifa A, Themistokli E, Strati A, Zavridou M, Tsaroucha E, Sfika A, Psyrri A, Balgouranidou I, Kotsakis A, Georgoulias V, Lianidou E. Cancers (Basel). 2026 May 28;18(11):1759. doi: 10.3390/cancers18111759. PMID: 42279342; PMCID: PMC13256021. |
| 10 | Analytical and clinical validation of a novel CE-IVD kit for PIK3CA hotspot mutations in liquid biopsy samples Stergiopoulou D, Smilkou S, Tzanikou E, Kaklamanis L, Georgoulias V, Koukli I, Markou A, Lianidou E. J Liq Biopsy. 2026 Feb 18;11:100458. doi: 10.1016/j.jlb.2026.100458. PMID: 41756001; PMCID: PMC12933448. |
| 11 | Epigenetics and CTCs: New biomarkers and impact on tumor biology Ntzifa A, Lianidou E. Int Rev Cell Mol Biol. 2025;392:177-198. doi: 10.1016/bs.ircmb.2024.03.002. Epub 2024 Jun 1. PMID: 40287220. |